company background image
A096530 logo

Seegene KOSDAQ:A096530 Stock Report

Last Price

₩23.75k

Market Cap

₩1.1t

7D

-0.4%

1Y

4.2%

Updated

24 Dec, 2024

Data

Company Financials +

A096530 Stock Overview

Manufactures and sells molecular diagnostics products worldwide. More details

A096530 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health4/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Seegene, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Seegene
Historical stock prices
Current Share Price₩23,750.00
52 Week High₩35,950.00
52 Week Low₩19,500.00
Beta-1.11
1 Month Change3.04%
3 Month Change-7.59%
1 Year Change4.17%
3 Year Change-61.51%
5 Year Change54.98%
Change since IPO464.58%

Recent News & Updates

Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Nov 22
Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Nov 12
Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Recent updates

Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Nov 22
Investors Shouldn't Be Too Comfortable With Seegene's (KOSDAQ:096530) Earnings

Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Nov 12
Is Seegene (KOSDAQ:096530) Using Too Much Debt?

Seegene, Inc.'s (KOSDAQ:096530) Share Price Boosted 44% But Its Business Prospects Need A Lift Too

Aug 10
Seegene, Inc.'s (KOSDAQ:096530) Share Price Boosted 44% But Its Business Prospects Need A Lift Too

A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Mar 07
A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?

May 06
Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?

I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Mar 15
I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Feb 25
Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?

Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?

Feb 08
Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?

What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?

Jan 22
What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?

Calculating The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Jan 07
Calculating The Fair Value Of Seegene, Inc. (KOSDAQ:096530)

Declining Stock and Solid Fundamentals: Is The Market Wrong About Seegene, Inc. (KOSDAQ:096530)?

Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About Seegene, Inc. (KOSDAQ:096530)?

Can You Imagine How Elated Seegene's (KOSDAQ:096530) Shareholders Feel About Its 656% Share Price Gain?

Dec 08
Can You Imagine How Elated Seegene's (KOSDAQ:096530) Shareholders Feel About Its 656% Share Price Gain?

I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Nov 24
I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease

Shareholder Returns

A096530KR BiotechsKR Market
7D-0.4%-1.2%-0.9%
1Y4.2%16.3%-9.0%

Return vs Industry: A096530 underperformed the KR Biotechs industry which returned 16.1% over the past year.

Return vs Market: A096530 exceeded the KR Market which returned -9% over the past year.

Price Volatility

Is A096530's price volatile compared to industry and market?
A096530 volatility
A096530 Average Weekly Movement5.4%
Biotechs Industry Average Movement8.8%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.7%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A096530 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A096530's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aJong-Yoon Chunwww.seegene.com

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes.

Seegene, Inc. Fundamentals Summary

How do Seegene's earnings and revenue compare to its market cap?
A096530 fundamental statistics
Market cap₩1.10t
Earnings (TTM)₩29.47b
Revenue (TTM)₩399.42b

37.2x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A096530 income statement (TTM)
Revenue₩399.42b
Cost of Revenue₩153.82b
Gross Profit₩245.60b
Other Expenses₩216.13b
Earnings₩29.47b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)637.76
Gross Margin61.49%
Net Profit Margin7.38%
Debt/Equity Ratio7.4%

How did A096530 perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

125%

Payout Ratio

Does A096530 pay a reliable dividends?

See A096530 dividend history and benchmarks
When do you need to buy A096530 by to receive an upcoming dividend?
Seegene dividend dates
Ex Dividend DateDec 27 2024
Dividend Pay DateApr 21 2025
Days until Ex dividend1 day
Days until Dividend pay date116 days

Does A096530 pay a reliable dividends?

See A096530 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:22
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Seegene, Inc. is covered by 20 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mujinn LeeCape Investment & Securities Co., Ltd.
David LeeCLSA
Jinhee KwakEugene Investment & Securities Co Ltd.